Previous 10 |
home / stock / mrv:cc / mrv:cc news
Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its second quarter 2022 financial results ...
Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced the appointment of Dale MacCandlish Weil to its Board of Director...
Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company) a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced that at its 2022 Virtual Annual Meeting of Shareholders held on Ma...
- Blexten Canadian Prescriptions Increased 21% Year-Over-Year - - Suvexx Canadian Prescriptions Increased 120% Year-Over-Year - Miravo to Hold Virtual Annual Meeting May 16th at 9:00 a.m. ET Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo He...
Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced that it has become aware that the United States’ Food &...
Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its first quarter 2022 financial results b...
• Monday, May 2 at 11:00 a.m. ET • Nuvo Pharmaceuticals ® Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today ann...
- Blexten Canadian Prescriptions Increased 21% Year-Over-Year - - Cambia Canadian Prescriptions Increased 8% Year-Over-Year - Miravo to Host Conference Call/Audio Webcast March 28th at 11:00 a.m. ET Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a M...
Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced it has been recognized in The Globe and Mail’s 2022 Report...
News, Short Squeeze, Breakout and More Instantly...
Nuvo Pharmaceuticals Inc. Company Name:
MRV:CC Stock Symbol:
TSXC Market:
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“ Miravo ” or the “ Company ”) is pleased to announce that it has obtained a final court order from the Ontario Superior Court of Justice (Commercial List) approving its previously announ...
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“ Miravo ” or the “ Company ”) is pleased to announce that, at today’s special meeting of shareholders (the “ Meeting ”), its shareholders (“ Shareho...
Shareholders are reminded to vote their common shares prior to the proxy voting deadline of 9:00 a.m. (Toronto Time) on March 3, 2023 Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“ Miravo ” or the “ Company ”) reminds it...